Cargando…
Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2
In the past two decades, pandemics of several fatal coronaviruses have posed enormous challenges for public health, including SARS-CoV (2003), MERS-CoV (2012), and SARS-CoV-2 (2019). Among these, SARS-CoV-2 continues to ravage the world today and has lead to millions of deaths and incalculable econo...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416071/ https://www.ncbi.nlm.nih.gov/pubmed/34483904 http://dx.doi.org/10.3389/fphar.2021.702472 |
_version_ | 1783748100796448768 |
---|---|
author | Chen, Wei Wang, Zhihao Wang, Yawen Li, Yiping |
author_facet | Chen, Wei Wang, Zhihao Wang, Yawen Li, Yiping |
author_sort | Chen, Wei |
collection | PubMed |
description | In the past two decades, pandemics of several fatal coronaviruses have posed enormous challenges for public health, including SARS-CoV (2003), MERS-CoV (2012), and SARS-CoV-2 (2019). Among these, SARS-CoV-2 continues to ravage the world today and has lead to millions of deaths and incalculable economic damage. Till now, there is no clinically proven antiviral drug available for SARS-CoV-2. However, the bioactive molecules of natural origin, especially medicinal plants, have been proven to be potential resources in the treatment of SARS-CoV-2, acting at different stages of the viral life cycle and targeting different viral or host proteins, such as PL(pro), 3CL(pro), RdRp, helicase, spike, ACE2, and TMPRSS2. They provide a viable strategy to develop therapeutic agents. This review presents fundamental biological information on SARS-CoV-2, including the viral biological characteristics and invasion mechanisms. It also summarizes the reported natural bioactive molecules with anti-coronavirus properties, arranged by their different targets in the life cycle of viral infection of human cells, and discusses the prospects of these bioactive molecules for the treatment of COVID-19. |
format | Online Article Text |
id | pubmed-8416071 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84160712021-09-04 Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2 Chen, Wei Wang, Zhihao Wang, Yawen Li, Yiping Front Pharmacol Pharmacology In the past two decades, pandemics of several fatal coronaviruses have posed enormous challenges for public health, including SARS-CoV (2003), MERS-CoV (2012), and SARS-CoV-2 (2019). Among these, SARS-CoV-2 continues to ravage the world today and has lead to millions of deaths and incalculable economic damage. Till now, there is no clinically proven antiviral drug available for SARS-CoV-2. However, the bioactive molecules of natural origin, especially medicinal plants, have been proven to be potential resources in the treatment of SARS-CoV-2, acting at different stages of the viral life cycle and targeting different viral or host proteins, such as PL(pro), 3CL(pro), RdRp, helicase, spike, ACE2, and TMPRSS2. They provide a viable strategy to develop therapeutic agents. This review presents fundamental biological information on SARS-CoV-2, including the viral biological characteristics and invasion mechanisms. It also summarizes the reported natural bioactive molecules with anti-coronavirus properties, arranged by their different targets in the life cycle of viral infection of human cells, and discusses the prospects of these bioactive molecules for the treatment of COVID-19. Frontiers Media S.A. 2021-08-17 /pmc/articles/PMC8416071/ /pubmed/34483904 http://dx.doi.org/10.3389/fphar.2021.702472 Text en Copyright © 2021 Chen, Wang, Wang and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Chen, Wei Wang, Zhihao Wang, Yawen Li, Yiping Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2 |
title | Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2 |
title_full | Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2 |
title_fullStr | Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2 |
title_full_unstemmed | Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2 |
title_short | Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2 |
title_sort | natural bioactive molecules as potential agents against sars-cov-2 |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416071/ https://www.ncbi.nlm.nih.gov/pubmed/34483904 http://dx.doi.org/10.3389/fphar.2021.702472 |
work_keys_str_mv | AT chenwei naturalbioactivemoleculesaspotentialagentsagainstsarscov2 AT wangzhihao naturalbioactivemoleculesaspotentialagentsagainstsarscov2 AT wangyawen naturalbioactivemoleculesaspotentialagentsagainstsarscov2 AT liyiping naturalbioactivemoleculesaspotentialagentsagainstsarscov2 |